These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 20969527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor.
    Bethke TD, Böhmer GM, Hermann R, Hauns B, Fux R, Mörike K, David M, Knoerzer D, Wurst W, Gleiter CH.
    J Clin Pharmacol; 2007 Jan; 47(1):26-36. PubMed ID: 17192499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Single-dose pharmacokinetics of roflumilast in children and adolescents.
    Neville KA, Szefler SJ, Abdel-Rahman SM, Lahu G, Zech K, Herzog R, Bethke TD, Gleason MC, Kearns GL.
    J Clin Pharmacol; 2008 Aug; 48(8):978-85. PubMed ID: 18508947
    [Abstract] [Full Text] [Related]

  • 9. No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidine.
    Böhmer GM, Gleiter CH, Mörike K, Nassr N, Walz A, Lahu G.
    J Clin Pharmacol; 2011 Apr; 51(4):594-602. PubMed ID: 20484614
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of single and repeated doses of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide.
    Lahu G, Huennemeyer A, von Richter O, Hermann R, Herzog R, McCracken N, Zech K.
    J Clin Pharmacol; 2008 Nov; 48(11):1339-49. PubMed ID: 18757786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide.
    Lahu G, Nassr N, Herzog R, Elmlinger M, Ruth P, Hinder M, Huennemeyer A.
    J Clin Pharmacol; 2011 Apr; 51(4):586-93. PubMed ID: 20466871
    [Abstract] [Full Text] [Related]

  • 16. Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.
    Huennemeyer A, Nassr N, Bredenbröker D, Lahu G.
    Expert Opin Drug Saf; 2011 Jul; 10(4):509-19. PubMed ID: 21585288
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of single- and multiple-dose roflumilast: an open-label, three-way crossover study in healthy Chinese volunteers.
    Huang J, Fu CX, Yang XY, Cui C, Yang S, Kuang Y, Guo CX, Hu P, Pei Q, Yang GP.
    Drug Des Devel Ther; 2018 Jul; 12():4047-4057. PubMed ID: 30538429
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses.
    Li Q, Wang Y, Liu L, Ma P, Ding L.
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):371-381. PubMed ID: 27306372
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous quantification and pharmacokinetic evaluation of roflumilast and its N-oxide in cynomolgus monkey plasma by LC-MS/MS method.
    Qu H, Zhang K, Fu C, Qiu F.
    Biomed Chromatogr; 2021 Feb; 35(2):e4973. PubMed ID: 32840886
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.